| Name | Title | Contact Details |
|---|
Somos una empresa internacional especializada en startups y empresas tech de LATAM. Acompañamos el crecimiento acelerado de los founders garantizándoles en cada etapa el cumplimiento de todos sus compromisos financieros, contables, impositivos y legales en cada país en el que operan. Nuestras soluciones contemplan servicios de compliance, impuestos internacionales, softlanding, CFO Services, transaction services y legal services. Nos caracterizamos por nuestra velocidad de respuesta, profesionalismo y calidad en la ejecución.
At Preciball USA, we have provided tailored precision and industrial balls to a wide variety of industries for nearly 100 years. This long standing commitment to excellence and dedication to our customers has earned us advanced expertise and a thorough understanding of hundreds of very specific applications and processes in industries around the globe. Our products are used in applications such as bearings, pumps, valves, swivel joints, transfer units, casters, oil and gas extraction, grinding and dispersion, sprayers, conveyors, and agitators... Materials include carbon, chrome, stainless steel, plastic, glass, phenolic resin, and exotic alloys. Our capabilities include engineering, research and development, custom product development and manufacturing.
DREAMSTAGE is a New York-based video streaming platform that allows artists to perform virtual musical concerts.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.